OOIR: Observatory of International Research

Papers

(The H4-Index of Allergy is 58. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
In this Issue: Graphical Abstracts	687
Issue Information	343
Issue Information	294
Issue Information	256
In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend	196
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update	189
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable	171
Type 2 memory B cells: The repository of allergic memory?	158
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy	149
TOP10‐SCAR: A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Reactions	145
	143
Algorithms in allergy: An algorithm for alpha‐Gal syndrome diagnosis and treatment, 2024 update	129
Prospective (e‐diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study	122
Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study	121
Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle	112
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”	107
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes	105
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”	101
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern	101
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma	99
Next generation health guidelines: The role of real‐life data in evidence‐based medicine	96
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2	94
Legends of allergology and immunology: Per Brandtzaeg – Pillar of mucosal immunology	93
25‐hydroxyvitamin D and risk of atopic diseases and infections in early childhood	86
Experimental rhinovirus infection induces an antiviral response in circulating B cells which is dysregulated in patients with asthma	85

Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial	83
Large scale regulatory T cells screening	82
Health effects of exposure to chlorination by‐products in swimming pools	82
In memoriam: Lawrence M. Lichtenstein (1934–2022)	81
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis	80
MUC1 deficiency induces the nasal epithelial barrier dysfunction via RBFOX3 shortage augment ubiquitin–proteasomal degradation in allergic rhinitis pathogenesis	80
Allergenic components of the mRNA‐1273 vaccine for COVID‐19: Possible involvement of polyethylene glycol and IgG‐mediated complement activation	77
Persistence of infectious SARS‐CoV‐2 particles for up to 37 days in patients with mild COVID‐19	74
Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice	73
Preclinical Development of GR2002, a Novel Anti‐TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects	73
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation	73
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures	72
Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants	72
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma	71
IgG Removal Enhances the Sensitivity of Amoxicillin‐Specific IgE Detection in ImmunoCAP and Radioallergosorbent Test	67
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis	66
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies	64
The Presence and Pathogenic Roles of M(IL‐33 + IL‐2) Macrophages in Allergic Airway Inflammation	63
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3⁺ Tregs	62
Immunoglobulin E response in health and disease beyond allergic disorders	62
Development and validation of the food allergy severity score	61
Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’	61
Hot topics in allergen immunotherapy, 2023: Current status and future perspective	61
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis	60
Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study	60
In this Issue: Graphical Abstracts	59
Impact of climate change on atopic dermatitis: A review by the International Eczema Council	59
Issue Information	59
Issue Information ‐ TOC	59
Issue Information	59
Allergoid‐mannan conjugates imprint tolerogenic features in human macrophages	58
What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders	58
Neuron−macrophage interaction in the healing process of the skin	58